Competition Analysis and Market Structure
Some leading players adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers & acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. Some of the key developments in the global anti-snoring devices market include. In December 2021, AppYea – one of the leading medical device technology companies, announced the deemed completion of its previously announced acquisition of SleepX, an innovative medical device company focused on the development of SleepX’s flagship product DreamIT – an uncompetitive accurate wearable monitoring solution to treat sleep apnea and snoring and fundamentally improve quality of life. Some of the prominent players and suppliers operating and contributing significantly to the global anti-snoring devices market growth include Endo Pharmaceuticals Inc., KARL STORZ SE & Co. KG, Lumenis., Olympus Winter & IBE GMBH, Urologix, LLC., Boston Scientific Corporation, LISA Laser USA, ProArc Medical, Urovision-Urotech, Teleflex Incorporated, Richard Wolf GmbH, biolitec AG, Coloplast Corp, Nozovent, SnoreRx, LLC, and Snoring Solutions, Inc., among others. RationalStat has segmented the global anti-snoring devices market based on type, distribution channel, end user, and region
Global Anti-Snoring Devices Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Type
Oral Appliances
For more information about this report- https://store.rationalstat.com/store/global-anti-snoring-devices-market/
Key Questions Answered in the Anti-Snoring Devices Report:
What will be the market value of the global Anti-Snoring Devices market by 2030? What is the market size of the global Anti-Snoring Devices market? What are the market drivers of the global Anti-Snoring Devices market? What are the key trends in the global Anti-Snoring Devices market? Which is the leading region in the global Anti-Snoring Devices market? What are the major companies operating in the global Anti-Snoring Devices market? What are the market shares by key segments in the global Anti-Snoring Devices market? Running a year End discount of 20%- https://store.rationalstat.com/store/global-anti-snoring-devices-market/#tab-ux_global_tab
Explore Our Trending Reports
Global RWE Oncology Market - Global RWE oncology market is expected to grow at a CAGR of around 13.2% during the forecast period of 2023-2030 and is estimated at US$ 720 million in 2023. Global Computed Radiography Market - Global computed radiography market is expected to grow at a CAGR of around 5.4% during the forecast period of 2023-2030 and is estimated at US$ 4.3 billion in 2023. Nigeria OTC Medications Market - Nigeria OTC medications market is expected to grow at a CAGR of around 13% during the forecast period of 2023-2028 and was valued at around US$ 2.2 billion in 2022. Global Sexually Transmitted Diseases Testing Market - Global sexually transmitted diseases testing market is expected to grow at a CAGR of around 7.6% during the forecast period of 2023-2028 and was valued at around US$ 8.5 billion in 2022. Global Human Microbiome Market - Global human microbiome market is expected to grow at a CAGR of around 18% during the forecast period of 2023-2030 and is estimated at US$ 650 million in 2023. Global Human Microbiome Market - Global human microbiome market is expected to grow at a CAGR of around 18% during the forecast period of 2023-2030 and is estimated at US$ 650 million in 2023. Global Swab Market - Global Swab Market is expected to grow at a CAGR of 6.6% over the forecast period of 2022-2028
Global Pet CBD (cannabidiol) Market - Global Pet CBD (cannabidiol) Market is expected to grow at a CAGR of 12.0% over the forecast period of 2022-2028
Global Medical Rehabilitation Service Market - Global Medical Rehabilitation Service Market is expected to grow at a CAGR of 6.1% over the forecast period of 2022-2028
Global Hepatitis B Virus Market - Global Hepatitis B Virus Market is expected to grow at a CAGR of 5.8% over the forecast period of 2022-2028
Global Hepatitis B Vaccine (Recombinant) Market - Global Hepatitis B Vaccine (Recombinant) Market is expected to grow at a CAGR of 5.6% over the forecast period of 2022-2028
Global Benign Prostatic Hyperpl Medication Market - Global Benign Prostatic Hyperpl Medication Market is expected to grow at a CAGR of 5.0% over the forecast period of 2022-2028
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting. RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
Defining the problem by understanding the type of market and data required by the client. Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews. Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance. Evaluating and analyzing the data by referring to data sources utilized and leveraged. Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts. About RationalStat LLC
RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually. RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client’s needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards. Contact

Latest Market Study | Anti-Snoring Devices Market Size, Share, Trends, Industry Analysis & Forecasts, 2023-2030

News Provided By
Share This Article
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market 2022 - Opportunities And Strategies – Global Forecast To 2030
TBRC’s Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2022: Market Size, Trends, And Forecast To 2026
Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!”
— The Business Research Company
LONDON, GREATER LONDON, UK, December 2, 2022 / EINPresswire.com / -- Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies! As per The Business Research Company's "Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Global Market Report 2022”, the BPH treatment devices and equipment market grew from $1.33 billion in 2021 to $1.46 billion in 2022 at a compound annual growth rate (CAGR) of 9.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The benign prostatic hyperplasia (BPH) treatment devices and equipment market is expected to grow to $1.86 billion in 2026 at a CAGR of 6.2%. Benign Prostatic Hyperplasia (BPH) also called Prostate Gland Enlargement (PGE), is a condition where the patient suffers from uncomfortable urinary symptoms. Request a free Sample now to gain a better understanding of BPH treatment devices and equipment market:
Key Trends In The Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Market
Prostatic Artery Embolization (PAE) is one of the latest developments in the market for Benign Prostatic Hyperplasia (BPH) treatment devices and equipment. PAE is a minimally invasive treatment that assists in reducing the symptoms observed in the urinary tract. The PAE procedure is done using X-rays and other advanced imaging to observe the tumor inside the body and accordingly treat it without any surgery. This technique results in reduced complications in the treatment of BPH and thus is said to be a major development in the market of BPH treatment. Leading companies such as Boston scientific, UNC healthcare, and Spire healthcare have been investing in the market for PAE. Overview Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Market
The benign prostatic hyperplasia (BPH) treatment devices and equipment market consists of sales of benign prostatic hyperplasia (BPH) treatment devices and equipment and related services. Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition of an enlarged prostate gland that causes blockage of the urethra, the tube that carries urine from the bladder. Market Size Data
• Forecast period: Historical and Future
• By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa. • By countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. Market Segmentation
• By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home
• By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
• By Geography: The global BPH treatment devices and equipment market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Major market players such as Karl Storz, Lumenis, Olympus, Urologix, Boston Scientific Inc., Endo International, Neo tract, Lisa Laser, Medifocus Inc., ProArc Medical LTD., and Olympus America. Trends, opportunities, strategies and so much more. Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Global Market Report 2022 is one of The Business Research Company’s comprehensive reports that provides benign prostatic hyperplasia (BPH) treatment devices and equipment market overview. The market report analyzes BPH treatment devices and equipment market size, benign prostatic hyperplasia (BPH) treatment devices and equipment market share, BPH treatment devices and equipment market growth drivers, benign prostatic hyperplasia (BPH) treatment devices and equipment market segmentation, BPH treatment devices and equipment market major players, BPH treatment devices and equipment market growth across geographies, benign prostatic hyperplasia (BPH) treatment devices and equipment market trends and BPH treatment devices and equipment market competitors’ revenues and market positioning. The BPH treatment devices and equipment market report enables you to gain insights on opportunities and strategies, as well as identify countries and segments with the highest growth potential. Not what you were looking for? Go through similar reports by The Business Research Company:
Prostate Cancer Drugs Global Market Report 2022

Insights Into Global Benign Prostatic Hyperplasia (BPH) Treatment Devices & Equipment Market 2022-2031 Forecast Period

| Emergen Research
News Provided By
Share This Article
Emergen Research Logo
Rapid advancements and innovation in prostate health treatments and rising need for hormone treatment medications are factors driving market revenue growth
VANCOUVER, BRITISH COLUMBIA, CANADA, November 7, 2022 / EINPresswire.com / -- The global prostate health market size was USD 32.07 Billion in 2021 and is expected to register a revenue CAGR of 9.1% during the forecast period, according to the latest analysis by Emergen Research. Technological advancements in prostate health treatments and rising investments, funds, and grants for research in BPH treatment are factors projected to support market revenue growth between 2022 and 2030. For example, on 02 July 2019, as a part of the European Innovation Council pilot, ProArc received a USD 2.2 million grant from Horizon 2020 program. This will help in ProArc's ClearRing BPH implant to be studied scientifically in greater detail and made available for purchase. In addition, rising prevalence of obesity across the globe, changes in endocrine function, oxidative stress, an uptick in inflammatory process, and increase in intra-abdominal pressure promote growth of BPH among men. Moreover, rising expenditures by governments of various countries to improve healthcare infrastructure and rising disposable income are factors driving revenue growth of the market. However, complications and side effects related to treatments are expected to hamper revenue growth of the market. Prostate cancer and its therapies, such as surgery, radiation, and hormone therapy, can also cause erectile dysfunction. These factors are expected to restrain revenue growth of the market. To receive a PDF sample of the report, visit @ https://www.emergenresearch.com/request-sample/1273
The prostate (prostate gland) is basically an organ of the reproductive system of a male. Prostate cancer, benign prostatic hyperplasia (BPH), and inflammation are the three most prevalent types of prostate disease (prostatitis). Benign prostatic hyperplasia (BPH), a disorder that affects males and causes the prostate gland to expand non-cancerously, is one of these. However, BPH seldom manifests any symptoms before to the age of 40, and as people age, so does their risk of developing BPD. This condition affects a large number of people, and surgery and drugs are utilised to address this medical condition. Therefore, in the next years, these factors are projected to propel the growth opportunities in the prostate health market. Global Prostate Health Market Highlights:
Regional demand estimation and forecast
Product Mix Matrix
Competitive Landscape:
The latest study provides an insightful analysis of the broad competitive landscape of the global prostate health market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. The report analyzes various elements of the market’s competitive scenario, such as the regulatory standards and policies implemented across the industry over recent years. Our team of experts has leveraged several powerful analytical tools, such as Porter’s Five Forces analysis and SWOT analysis, to deliver a comprehensive overview of the global prostate health market and pinpoint the fundamental growth trends. Overview of the prostate health Market Report:
Introduction, Product Scope, Market Overview, and Opportunities
Analysis of the Manufacturers with sales, revenue, and price analysis
Comprehensive analysis of the competitive landscape
Extensive profiling of the key competitors along with their business strategies and market size
Regional analysis of the market along with sales, revenue, market share, and global position
Country-wise analysis of the market along with types, applications, and manufacturing
Strategic recommendations to established players as well as new entrants
In-depth analysis of the risks, restraints, and limitations in the prostate health industry
Request Customization of the Report @ https://www.emergenresearch.com/request-for-customization/1273
Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements. Explore More Reports by Emergen Research:
Smart Farming Market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. Eric Lee

Prostate Health Market Booming Worldwide with Industry Analysis, Upcoming Trend, Future Scope by 2030 | Emergen Research

News provided by
Share this article
Share this article
NEW YORK, Nov. 1, 2022 /PRNewswire/ -- The benign prostatic hyperplasia (BPH) devices market size is expected to grow by USD 3.34 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 5.09% during the forecast period, according to Technavio. The increasing prevalence of BPH coupled with increasing risk factors is driving the benign prostatic hyperplasia (BPH) devices market growth. However, factors such as the high cost of BPH treatment may challenge the market growth
Technavio has announced its latest market research report titled Global Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026
View a comprehensive report summary that describes the market size and forecast along with the research methodology. The FREE sample report  is available in PDF format
Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026: Scope
The benign prostatic hyperplasia (BPH) devices market report covers the following areas:
Rest Of World (ROW)
37% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for benign prostatic hyperplasia (BPH) devices in North America. The growing elderly population, rising incidence of BPH, and perpetual innovations in BPH devices will facilitate the benign prostatic hyperplasia (BPH) devices market growth in North America over the forecast period. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026: Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the benign prostatic hyperplasia (BPH) devices market, including Astellas Pharma Inc., biolitec AG, Boston Scientific Corp., Butterfly Medical, Coloplast AS, Convergent Laser Technologies, IPG Photonics Corp., KARL STORZ SE and Co. KG, Medeon Biodesign Inc., Medifocus Inc., Olympus Europa SE and Co. KG, OmniGuide Holdings Inc., ProArc Medical, PROCEPT BioRobotics Corp., Richard Wolf GmbH, SRS Medical, Teleflex Inc., Urologix LLC, Vendor Credentialing Service LLC dba symplr, and Zenflow Inc. This report provides a full list of key vendors, their strategies, and the latest developments. Buy Now  for detailed vendor information
Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026: Key Highlights
CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will assist benign prostatic hyperplasia (BPH) devices market growth during the next five years
Estimation of the benign prostatic hyperplasia (BPH) devices market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the benign prostatic hyperplasia (BPH) devices market
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of benign prostatic hyperplasia (BPH) devices market vendors
Related Reports:
Companies profiled
Astellas Pharma Inc., biolitec AG, Boston Scientific Corp., Butterfly Medical, Coloplast AS, Convergent Laser Technologies, IPG Photonics Corp., KARL STORZ SE and Co. KG, Medeon Biodesign Inc., Medifocus Inc., Olympus Europa SE and Co. KG, OmniGuide Holdings Inc., ProArc Medical, PROCEPT BioRobotics Corp., Richard Wolf GmbH, SRS Medical, Teleflex Inc., Urologix LLC, Vendor Credentialing Service LLC dba symplr, and Zenflow Inc.
Market Dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. Table Of Contents :
Exhibit 27: Data Table on Comparison by Therapy
5.3 TURP - Market size and forecast 2021-2026
Exhibit 28: Chart on TURP - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on TURP - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on TURP - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on TURP - Year-over-year growth 2021-2026 (%)
5.4 Laser therapy - Market size and forecast 2021-2026
Exhibit 32: Chart on Laser therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Laser therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Laser therapy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Laser therapy - Year-over-year growth 2021-2026 (%)
5.5 Others - Market size and forecast 2021-2026
Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Therapy
Exhibit 40: Market opportunity by Therapy ($ million)
6 Customer Landscape
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 France - Market size and forecast 2021-2026
Exhibit 66: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on France - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Ireland - Market size and forecast 2021-2026
Exhibit 74: Chart on Ireland - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Ireland - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Ireland - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Ireland - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9.3 Landscape disruption
9.4 Industry risks
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

02:45 EDT
Benign Prostatic Hyperplasia (BPH) Devices Market to Grow by USD 3.34 Bn, TURP to be Largest Revenue-generating Therap...

Sunnybrook

Rambam Medical Campus

Nephera

GeneGrafts

Corassist Cardiovascular

Technion Israel Institute of Technology

Tel Aviv University

Unattributed VC

ProArc Medical focuses on the development of minimally invasive medical devices for the urology sector, specifically addressing Benign Prostatic Hyperplasia (BPH). The company's product, Omega, is a non-surgical procedure intended to restore urinary function and address Lower Urinary Tract Symptoms (LUTS) related to BPH. ProArc Medical's technology aims to provide a solution that reduces complications. It is based in Caesarea Business Park, Israel.

Date	9/2/2020
Round	Unattributed VC
Amount
Investors	The Trendlines Group
Valuation	$XXM
Revenue	0 FY undefined
Sources

First funding	9/2/2020
Last Funding	9/2/2020
Investor	The Trendlines Group
Rounds	1 Unattributed VC
Board Seats
Type	Venture Capital
Location	Israel

How VCs Use CB Insights

Professional Services

Platform Overview

ProArc Medical

Investors Count

Funding, Valuation & Revenue

ProArc Medical Investors